Description
NAD⁺ Peptide: Mitochondrial Support and Cellular Vitality
Overview
NAD⁺ (Nicotinamide Adenine Dinucleotide) peptide is a critical molecule involved in cellular energy production, mitochondrial function, and overall cellular repair. In the practice of Dr. Saul Maslavi, NAD⁺ peptide is a vital part of peptide therapy, helping patients achieve improved energy, cognitive function, and overall wellness through optimized cellular health.
Mechanism of Action
NAD⁺ peptides work by boosting NAD⁺ levels within cells, which are essential for mitochondria — the “powerhouses” of the cell. Mitochondria rely on NAD⁺ to generate ATP, the body’s energy currency, while supporting DNA repair, detoxification, and cellular resilience. By increasing NAD⁺ availability, this peptide enhances mitochondrial efficiency, reduces oxidative stress, and activates longevity pathways such as sirtuins.
Clinical Benefits
- Enhanced Energy & Vitality: Supports ATP production, reducing fatigue and improving mental and physical performance.
- Mitochondrial Health: Promotes efficient cellular energy production and protects against mitochondrial dysfunction, a key factor in aging and chronic disease.
- DNA Repair & Longevity: Supports healthy aging by enhancing DNA repair and cellular resilience.
- Cognitive Support: Improves neuronal function and mental clarity through optimized energy availability in brain cells.
- Integral to Wellness Programs: Works synergistically with other peptides in Dr. Saul Maslavi’s practice to support recovery, metabolic function, and long-term health.
Conclusion
In the practice of Dr. Saul Maslavi, NAD⁺ peptide is a cornerstone of mitochondrial health and cellular vitality. By enhancing energy production, supporting DNA repair, and improving mitochondrial efficiency, it provides essential benefits for overall wellness, anti-aging strategies, and optimized patient outcomes. Incorporating NAD⁺ peptide therapy helps patients feel more energetic, resilient, and healthier at the cellular level.

Reviews
There are no reviews yet.